Stay updated on IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial
Sign up to get notified when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.

Latest updates to the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page; no visible edits to study details, contacts, locations, or other content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedResults Submitted is now shown, indicating that study results have been submitted. Outdated notices about funding status and 'No Results Posted' have been removed.SummaryDifference0.4%

- Check34 days agoChange DetectedNo significant changes detected in the Study Details page; the content remains the same.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision.SummaryDifference3%

- Check69 days agoChange DetectedUpdated revision to v3.1.0 with new contact details (medaly@ucdavis.edu, 916-734-5428) and removed prior topic (head and neck squamous cell carcinoma); core page content appears to be updated mainly through versioning and contact information, with a notable removal of a medical topic.SummaryDifference0.2%

- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, signaling a new release. The 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IL-2 Combo for Refractory Checkpoint Blockade Clinical Trial page.